Kidney Care Partners called CMS’ final 2024 end-stage renal disease pay rule a “slap in the face” Friday (Oct. 27) as the coalition says the rule’s 2.1% pay update is grossly insufficient and the agency has set up a pay cliff with its post-Transitional Drug Add-on Payment Adjustment pay policy finalized in Friday’s rule. The partners, which include ESRD patient groups, dialysis providers, nurses and others, say Congress needs to step in and pass the bipartisan Chronic Kidney Disease Improvement...